Evidence map›Paper›PMID 31733589›Full record

ArticleDNA repair2020

Recognition of DNA adducts by edited and unedited forms of DNA glycosylase NEIL1.

Irina G Minko, Vladimir L Vartanian, Naoto N Tozaki, Erdem Coskun, Sanem Hosbas Coskun, Pawel Jaruga, Jongchan Yeo, Sheila S David, Michael P Stone, Martin Egli and 3 more

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Aflatoxin BEnvironmental and molecular mutagenesis · 2025
    Article
  6. Review
  7. Research progress on the role of the NEIL family in cancer.Frontiers in cell and developmental biology · 2025
    Review
  8. Article
  9. Frequencies and spectra of aflatoxin BNAR molecular medicine · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Irina G MinkoOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR 97239, United States.
Vladimir L VartanianOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR 97239, United States.
Naoto N TozakiOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR 97239, United States.
Erdem CoskunBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, United States; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850, United States.
Sanem Hosbas CoskunBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, United States.
Pawel JarugaBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, United States.
Jongchan YeoDepartment of Chemistry, University of California, Davis, CA 95616, United States.
Sheila S DavidDepartment of Chemistry, University of California, Davis, CA 95616, United States.
Michael P StoneDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, United States.
Martin EgliDepartment of Biochemistry, Vanderbilt University, Nashville, TN 37232, United States.
Miral DizdarogluBiomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, United States.
Amanda K McCulloughOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR 97239, United States; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, United States.
R Stephen LloydOregon Institute of Occupational Health Sciences, Oregon Health & Science University, Portland, OR 97239, United States; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, United States; Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, OR 97239, United States. Electronic address: lloydst@ohsu.edu.
Oregon Health & Science University · USMaterial Measurement Laboratory · USUniversity of California, Davis · USVanderbilt University · USAdvanced Bioscience Laboratories (United States) · US

Funding

Synthetic Approaches to Carcinogen-Linked OligonucleotidesP01CA160032 · NCI · VANDERBILT UNIVERSITY · PI STONE, MICHAEL P · 2012 to 2022
$14.0M
Chemistry and Biology of Oxidized Purine Lesions in DNAR01CA090689 · NCI · UNIVERSITY OF UTAH · PI BURROWS, CYNTHIA J, DAVID, SHEILA SUE · 2002 to 2019
$5.5M
DNA Adduct-Induced MutagenesisR01CA055678 · NCI · VANDERBILT UNIVERSITY · PI STONE, MICHAEL P · 1992 to 2016
$4.0M
DNA Adduct-Induced MutagenesisR01ES029357 · NIEHS · VANDERBILT UNIVERSITY · PI STONE, MICHAEL P · 2018 to 2022
$2.6M
Role of Base Excision Repair in Limiting Hepatocellular Carcinomas -Administrative SupplementR01ES031086 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LLOYD, R. STEPHEN · 2020 to 2024
$2.0M
The roles of BER and TLS in limiting aflatoxin-induced carcinogenesisR56ES027632 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LLOYD, R. STEPHEN · 2017 to 2017
$308k
NCI NIH HHS P01 CA160032NCI NIH HHS R01 CA055678NCI NIH HHS R01 CA090689NIEHS NIH HHS R01 ES029357NIEHS NIH HHS R01 ES031086NIEHS NIH HHS R56 ES027632
6 · The paper itself

Abstract

Pre-mRNA encoding human NEIL1 undergoes editing by adenosine deaminase ADAR1 that converts a single adenosine to inosine, and this conversion results in an amino acid change of lysine 242 to arginine. Previous investigations of the catalytic efficiencies of the two forms of the enzyme revealed differential release of thymine glycol (ThyGly) from synthetic oligodeoxynucleotides, with the unedited form, NEIL1 K242 being ≈30-fold more efficient than the edited NEIL1 K242R. In contrast, when these enzymes were reacted with oligodeoxynucleotides containing guanidinohydantoin or spiroiminohydantoin, the edited K242R form was ≈3-fold more efficient than the unedited NEIL1. However, no prior studies have investigated the efficiencies of these two forms of NEIL1 on either high-molecular weight DNA containing multiple oxidatively-induced base damages, or oligodeoxynucleotides containing a bulky alkylated formamidopyrimidine. To understand the extent of changes in substrate recognition, γ-irradiated calf thymus DNA was treated with either edited or unedited NEIL1 and the released DNA base lesions analyzed by gas chromatography-tandem mass spectrometry. Of all the measured DNA lesions, imidazole ring-opened 4,6-diamino-5-formamidopyrimidine (FapyAde) and 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua) were preferentially released by both NEIL1 enzymes with K242R being ≈1.3 and 1.2-fold more efficient than K242 on excision of FapyAde and FapyGua, respectively. Consistent with the prior literature, large differences (≈7.5 to 12-fold) were measured in the excision of ThyGly from genomic DNA by the unedited versus edited NEIL1. In contrast, the edited NEIL1 was more efficient (≈3 to 5-fold) on release of 5-hydroxycytosine. Excision kinetics on DNA containing a site-specific aflatoxin B

Indexed as

Amino Acid SubstitutionAdenosine DeaminaseCatalytic DomainDNA AdductsDNA GlycosylasesGas Chromatography-Mass SpectrometryGene EditingHumansModels, MolecularMolecular WeightProtein ConformationRNA-Binding ProteinsSubstrate SpecificityADAR protein, humanAdenosine DeaminaseDNA AdductsDNA GlycosylasesNEIL1 protein, humanRNA-Binding ProteinsAflatoxinBase excision repairFormamidopyrimidinesHepatocellular carcinomaRNA editingThymine glycol

Identifiers

PMID31733589
PMCPMC7069121
OpenAlexW2984640760

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.